Consumer Protection commissioner proposes new medical marijuana conditions
Commissioner Harris agreed with all recommendations made by the Board of Physicians saying, “The Board of Physicians provides excellent guidance and advice to the Medical Marijuana Program in Connecticut. Our program remains one of the nation’s best because of its security, and thoughtful expansion. We make all of our decisions regarding the program with the goal of providing the best health care possible, and don’t make decisions without serious consultation with the medical community. We’re proud that our program has grown to help over 16,000 severely ill patients lead better lives in our state.”
The recommendations regarding the submitted petitions are below:
|Submitted Condition||Changes/Limits to Conditions Recommended by Board||Recommended to be Added for Adults||
be Added for Minors
|Fibromyalgia||Recommended as “Spasticity or Neuropathic Pain Associated with Fibromyalgia”||Yes||No|
|Rheumatoid Arthritis||Recommended as “Severe Rheumatoid Arthritis”||Yes||No|
|Post Herpetic Neuralgia, Peripheral Neuropathy and Allodynia from Shingles||Recommended as “Post Herpetic Neuralgia”||Yes||No|
|Atopic Dematitis, Eczema||N/A||No||No|
After DCP drafts a regulation to add the conditions, there will be an additional public hearing and comment period, the regulation then will be reviewed by the Office of the Attorney General, and ultimately require the approval of the Regulation Review Committee of the General Assembly.
There are currently 16,388 medical marijuana patients, and 629 certifying physicians registered with the state’s program. Today, are 22 conditions that qualify adult patients for medical marijuana, and six conditions that qualify patients under 18. The Board of Physicians consists of nine members found here.
A copy of the Commissioner’s letter to the Board of Physicians can be found here.